SUBSCRIBE
SUBSCRIBE

Cyclacel Pharmaceuticals Inc.

NEWS
Business
Cyclacel Pharma To Release First Quarter 2017 Financial Results
May 5, 2017
 · 
3 min read
Load More
JOBS
IN THE PRESS
Business
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
 · 
3 min read
Press Releases
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter
September 3, 2024
 · 
3 min read
Press Releases
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 15, 2024
 · 
7 min read
Press Releases
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
August 7, 2024
 · 
3 min read
Drug Development
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
June 4, 2024
 · 
7 min read
Pharm Country
Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
June 3, 2024
 · 
7 min read
Business
Cyclacel Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
 · 
8 min read
Business
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
May 8, 2024
 · 
3 min read
Pharm Country
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
May 2, 2024
 · 
4 min read
Pharm Country
Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 30, 2024
 · 
4 min read
Load More